PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma

Overview of attention for article published in Journal of Hematology & Oncology, October 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 230 Dimensions

Readers on

mendeley: 104 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS FOR TREATING LYMPHOMAS

Application EP-3692174-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.